NASDAQ$ZYXIQ

Zynex Inc · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

Zynex reported Q1 2025 revenue of $26.6M, a net loss of $10.4M.

For Q1 2025, Zynex reported Revenue was $26.6M, net loss was $10.4M. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Revenue $26.6M for Q1 2025.
  • Net loss $10.4M.
  • MD&A highlights operating priorities, liquidity, and sector risks.

Headline financials

Total Revenue

$26.6M

Previous: $46.5M-42.9%
EPS

-$0.33

Previous: $0.00
Capital Expenditures

-$168K

Previous: -$153K-9.8%
Free Cash Flow

-$10.7M

Previous: $1.92M-657.2%
Net Income

-$10.4M

Previous: $10K-104060.0%
Operating Income

-$13.1M

Previous: $525K-2594.7%
Gross Profit

$18.2M

Previous: $37.2M-51.1%

Revenue & EPS history

Zynex · Revenue · Quarterly

$26.6M

Q1 2025-42.9%vs Q1 2024
Beat estimate in 7 of 16 quarters(44%)
ActualEstimate

Revenue by segment

Zynex · $49.9M total across 2 segments · Q3 2023

  • Supplies
    $33.1M
  • Devices
    $16.9M

Forward guidance

Biotech outlook emphasizes pipeline milestones, commercial uptake, and cash runway.

Tailwinds

  • Product launches and label expansions can re-rate revenue.
  • Cash supports operating plans into key readouts.

Headwinds

  • Operating losses until commercial scale.
  • Reimbursement and competition affect uptake pace.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+0.4%

Avg return

Earnings day

-1.8%

Avg return

5 days after

-6.5%

Avg return

30 days after

46%

29 / 63 earnings

Positive

+38.5%

Q3 2014

Best reaction

-51.6%

Q1 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2024-51.3%
Q3 2025+0.0%+0.0%-98.2%
Q2 2025+0.0%+0.0%+0.0%
Q1 2025-25.6%+0.0%+0.0%
Q3 2024+9.1%+0.0%+0.0%
Q2 2024-11.4%+0.0%+0.0%
Q1 2024+2.8%+0.0%+0.0%
Q4 2023-8.8%+0.0%+0.0%
Q3 2023+17.5%+0.0%+0.0%
Q2 2023+3.3%+0.0%+0.0%
Q1 2023+2.5%+0.0%+0.0%
Q4 2022+16.7%+0.0%+0.0%
Q3 2022+15.0%+0.0%+0.0%
Q2 2022+13.3%+0.0%+0.0%
Q1 2022-8.6%+0.0%+0.0%
Q4 2021-1.7%+0.0%+0.0%
Q3 2021+10.0%+0.0%+0.0%
Q2 2021-19.3%+0.0%+0.0%
Q1 2021-9.2%-12.0%-6.3%
Q4 2020-21.2%-22.4%-18.8%
Q3 2020-6.5%
Q2 2020-6.0%
Q1 2020-1.1%
Q4 2019+3.1%
Q3 2019-7.9%
Q2 2019+9.8%
Q1 2019+7.9%
Q4 2018-11.1%
Q3 2018+3.4%
Q2 2018-3.3%
Q1 2018+4.5%
Q4 2017-20.7%
Q3 2017+6.6%
Q2 2017+34.6%
Q1 2017-5.6%
Q4 2016+9.7%
Q3 2016+23.1%
Q2 2016+34.8%
Q1 2016+0.0%
Q4 2015+0.0%
Q3 2015-4.3%
Q2 2015-5.4%
Q4 2014+0.0%
Q1 2015+0.0%
Q3 2014+38.5%
Q2 2014+2.2%
Q1 2014-0.2%
Q4 2013-3.6%
Q3 2013+13.6%
Q2 2013+7.1%
Q1 2013+0.0%
Q4 2012+3.4%
Q3 2012+5.6%
Q2 2012-5.1%
Q1 2012-6.3%
Q4 2011+0.0%
Q3 2010+12.9%
Q3 2011+12.9%
Q2 2011+1.1%
Q1 2011-8.2%
Q4 2010+0.0%
Q2 2010+2.0%
Q1 2010-51.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro